<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Okazaki, T.</title>
    <link>http://repub.eur.nl/res/aut/12357/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Clinical and Molecular Aspects of Stress on the Developing Lungs (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/20064/</link>
      <pubDate>1999-11-25T00:00:00Z</pubDate>
      <description>Growth and development are nmdamental processes and understanding of the mechanisms
resulting in abnonnal growth and development fonn the core of pediatrics and pediatric
surgery.
ivIany acute problems in the perinatal period mise from premahlrity and congenital
anomalies. AWlOugh mOltality is steadily decreasing due to progress in h'cahnent
modalities and prenatal diagnosis, remaining life-long morbidity is increasingly impOltanL
hI many of these children such as premahu'e newboms witll respiratOlY dish'ess syndrome
(ROS), abnOlmal pulmonary development in case of congenital diapluagmatic hemia
(CDR) or oligohydrarmuos associated with prolonged mphlre of membrarles arId renal
anomalies (the so called Potter sequence) the lungs are the tar'get orgarl for treatment.</description>
    </item> <item>
      <title>Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension (Article)</title>
      <link>http://repub.eur.nl/res/pub/9084/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Pulmonary hypoplasia accompanied by pulmonary hypertension
          resistant to treatment is an important feature of congenital diaphragmatic
          hernia (CDH). The pathogenesis of the pulmonary vascular abnormalities in
          CDH remains to be elucidated at the molecular level. Vascular endothelial
          growth factor (VEGF), an endothelial cell specific mitogen, is known to
          play a role in pulmonary angiogenesis and vascular remodelling but there
          are no data on VEGF expression in patients with CDH. METHODS: Necroscopic
          lung specimens from 21 patients with CDH with lung hypoplasia and from
          seven age matched control newborn infants without lung hypoplasia were
          processed for immunohistochemical analysis using affinity purified
          anti-human VEGF antibodies. All the cases of CDH had pulmonary hypoplasia,
          indicated by a lung/body weight index of &lt;/=0.012, and pulmonary
          hypertension indicated by repeated cardiac ultrasonography. Cellular
          localisation of VEGF was semiquantitatively analysed using a staining
          score ranging from 0 (no staining) to 4 (very strong staining). RESULTS:
          Significantly raised levels of VEGF immunoreactivity were observed in lung
          specimens from cases of CDH compared with controls. VEGF was detected
          mainly in the bronchial epithelium and the medial smooth muscle cells of
          large (&gt;200 microm) and small (&lt;200 microm) pulmonary arteries, the most
          intense staining being in the medial smooth muscle cells of the small
          pulmonary arteries. Endothelial cells were positive for VEGF staining in
          patients with CDH but not in controls. CONCLUSIONS: This is the first
          study of VEGF expression in newborn infants with CDH. Increased levels of
          VEGF, especially in the small, pressure regulating pulmonary arteries,
          point to a potential role in vascular remodelling. This may reflect an
          unsuccessful attempt by the developing fetus to increase the pulmonary
          vascular bed in the hypoplastic lungs to alleviate the associated
          pulmonary hypertension.</description>
    </item>
  </channel>
</rss>